Reversible cardiac dysfunction associated with pandemic 2009 influenza A(H1N1)

Chest

Volumn 137, Issue 5, 2010, Pages 1195-1197

  Martin, Seth S ^a   Hollingsworth, Caroline L ^a   Norfolk, Stephanie G ^a   Wolfe, Cameron R ^a   Hollingsworth, John W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; INFUSION FLUID; OSELTAMIVIR; OXYGEN; STEROID;

ABNORMAL RESPIRATORY SOUND; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASTHMA; BACTERIAL PNEUMONIA; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FEVER; FOLLOW UP; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTENSION; HYPOXEMIA; INFLUENZA; INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; MALE; PANDEMIC; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHOCK; SORE THROAT; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; UNITED STATES; VIRUS STRAIN;

EID: 77951786561     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-0032     Document Type: Article

References (5)

1. Gurevich VS. Influenza, autoimmunity and atherogenesis. Autoimmun Rev. 2005;4(2):101-105.
2. Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol. 2008;130(3):304-309.
3. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9(10): 601-610.
4. Karjalainen J, Nieminen MS, Heikkilä J. Influenza A1 myocarditis in conscripts. Acta Med Scand. 1980;207(1-2): 27-30.
5. Onitsuka H, Imamura T, Miyamoto N, et al. Clinical manifestations of influenza a myocarditis during the influenza epidemic of winter 1998-1999. J Cardiol. 2001;37(6):315-323. (Pubitemid 32634484)